Overview

Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis

Status:
Suspended
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety of combining phospholipids with medicinal plants for treatment of patients with amyotrophic lateral sclerosis (ALS)
Phase:
Phase 1
Details
Lead Sponsor:
Herb Spirit
Collaborator:
Carmel Medical Center